Curigliano Giuseppe
Full professor
Scientific-Disciplinary Sector
MEDS-09/A - Medical Oncology
Scientific-Disciplinary Group/Competition Sector
06/MEDS-09 - MALATTIE DEL SANGUE, ONCOLOGIA E REUMATOLOGIA
Research fields and competencies
Contacts
Workplace
University email address
Teaching - Programme courses
Bachelors and masters
A.Y. 2025/2026
A.Y. 2024/2025
A.Y. 2023/2024
A.Y. 2022/2023
A.Y. 2021/2022
A.Y. 2020/2021
Postgraduate programmes
A.Y. 2024/2025
Advanced course
- Attività didattica del corso di perfezionamento (Metodologia Ed Etica Della Sperimentazione Clinica Oncologica (MZ8))
2nd level vocational master
- A Comparison of Leading Institutions in Conducting Phase I Trials: Innovations and Results (Early Phase Clinical Trials in Oncology and Hemato-Oncology: from Preclinical Research to Study Design and Management)
- Etiopathogenesis of the Tumor (Master in Psiconcologia - Ii Livello)
- Immunological Therapy and New Biotechnological Approaches in Oncology (Master in farmacia e farmacologia oncologica - ii livello)
- Molecular Tumor Board (Molecular Pathology and Molecular Tumor Board)
A.Y. 2023/2024
Advanced course
- Attività didattica del corso di perfezionamento (Metodologia Ed Etica Della Sperimentazione Clinica Oncologica (MZ8))
- Attività didattica del corso di perfezionamento (Artificial Intelligence in Medical Oncology)
2nd level vocational master
- Immunological Therapy and New Biotechnological Approaches in Oncology (Master in farmacia e farmacologia oncologica - ii livello)
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
- Farmacologia medica 3 (Postgraduate School of Clinical Pharmacology and Toxicology)
- Farmacologia medica 3 (Postgraduate School of Clinical Pharmacology and Toxicology Reserved for Non-Doctors)
- Oncologia medica 2 (Postgraduate School of Medical Oncology)
- Oncologia medica 3 (Postgraduate School of Medical Oncology)
- Oncologia medica 4 (Postgraduate School of Medical Oncology)
- Oncologia medica 5 (Postgraduate School of Medical Oncology)
- Oncologia medica tronco comune (Psotgraduate School of Nuclear Medicine)
- Oncologia medica tronco comune (Postgraduate School of Diagnostic and Interventional Radiology)
- Oncologia medica tronco comune (Postgraduate School of Radiation Oncology)
A.Y. 2022/2023
2nd level vocational master
- Immunological Therapy and New Biotechnological Approaches in Oncology (Master in farmacia e farmacologia oncologica - ii livello)
- Tumour Aetiology, Treatment Paths, and Integration of Psycho-Oncology (Master in Psiconcologia - Ii Livello)
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
- Farmacologia medica 3 (Postgraduate School of Clinical Pharmacology and Toxicology Reserved for Non-Doctors)
- Farmacologia medica 3 (Postgraduate School of Clinical Pharmacology and Toxicology)
- Oncologia medica 2 (Postgraduate School of Medical Oncology)
- Oncologia medica 3 (Postgraduate School of Medical Oncology)
- Oncologia medica 4 (Postgraduate School of Medical Oncology)
- Oncologia medica 5 (Postgraduate School of Medical Oncology)
- Oncologia medica tronco comune (Psotgraduate School of Nuclear Medicine)
- Oncologia medica tronco comune (Postgraduate School of Radiation Oncology)
- Oncologia medica tronco comune (Postgraduate School of Diagnostic and Interventional Radiology)
Research
Publications
-
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact / K. Venetis, C. Frascarelli, L.B. Bielo, G. Cursano, R. Adorisio, M. Ivanova, E. Mane, V. Peruzzo, A. Concardi, M. Negrelli, M. D'Ercole, F.M. Porta, Y. Zhan, A. Marra, D. Trapani, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, N. Fusco. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - 217:(2025 Feb 25), pp. 115233.1-115233.10. [10.1016/j.ejca.2025.115233]
-
Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer / P.P.M. Berton Giachetti, S. Morganti, S. Gandini, F. Giudici, A. Marra, E. Nicolò, E. Zattarin, C. Corti, L. Boldrini, A. Verrazzo, C. Sposetti, M.G. Razeti, A. Carnevale Schianca, R. Scafetta, B. Taurelli Salimbeni, A. Esposito, P. Zagami, D. Trapani, B. Malagutti, R. Caputo, C. Vernieri, E. Munzone, S. Scagnoli, A. Botticelli, M. Lambertini, M. Giuliano, M. De Laurentiis, G. Viale, G. Bianchini, G. Curigliano, C. De Angelis, C. Criscitiello. - In: JAMA NETWORK OPEN. - ISSN 2574-3805. - 8:2(2025 Feb), pp. e2461067.1-e2461067.16. [10.1001/jamanetworkopen.2024.61067]
-
Advancing treatment choices: CDK4/6 inhibitor switching in HR+/HER2- metastatic breast cancer / P. Zagami, A. Esposito, B. Taurelli Salimbeni, P.P.M. Berton Giachetti, R. Scafetta, M. Lambertini, M. Di Maio, G. Curigliano, C. Criscitiello, S. Cinieri. - In: THE BREAST. - ISSN 0960-9776. - 79:(2025 Feb), pp. 103875.1-103875.8. [10.1016/j.breast.2025.103875]
-
Innovative payloads for ADCs in cancer treatment: moving beyond the selective delivery of chemotherapy / D. Izzo, L. Ascione, L. Guidi, R.M. Marsicano, C. Koukoutzeli, D. Trapani, G. Curigliano. - In: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. - ISSN 1758-8340. - 17:(2025), pp. 17588359241309461.1-17588359241309461.16. [10.1177/17588359241309461]
-
Estrogen Signaling in Early-Stage Breast Cancer: Impact on Neoadjuvant Chemotherapy and Immunotherapy / C. Corti, B. Binboğa Kurt, B. Koca, T. Rahman, F. Conforti, L. Pala, G. Bianchini, C. Criscitiello, G. Curigliano, A.C. Garrido-Castro, S.K. Kabraji, A.G. Waks, E.A. Mittendorf, S.M. Tolaney. - In: CANCER TREATMENT REVIEWS. - ISSN 0305-7372. - 132:(2025 Jan), pp. 102852.1-102852.14. [10.1016/j.ctrv.2024.102852]